Reposted by Solomon Rotimi, PhD
New research in TCRT @tcrtcancer.bsky.social identifies pathogenic BRCA1/2 variants in Nigerian breast cancer patients, highlighting the need for genetic screening.
bit.ly/4m3eX2L; bit.ly/42uWdBr
@solomonrotimi.bsky.social @journals.sagepub.com
#BreastCancer #Genetics #CancerResearch
bit.ly
Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients - Abimbola F. Onyia, Paul Jibrin, Temitope Olatunji-Agunbiade, Ademola Oyekan, AbdulRazzaq Lawal, Adewumi Alabi, Antho...
Background Breast cancer remains a leading cause of mortality among Nigerian women, with triple-negative breast cancer (TNBC) being particularly prevalent. Vari...
